Global Herceptin (Trastuzumab) Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Herceptin (Trastuzumab) is a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor from attaching to Her2. Herceptin also stimulates the body's own immune cells to destroy cancer cells. Clinically, it is mainly used for metastatic breast cancer with excessive expression of her-2. Monotherapy may be used for metastatic breast cancer that has received one or more chemotherapy regimens; It can be combined with paclitaxel to treat metastatic breast cancer without chemotherapy.
LPI (LP Information)' newest research report, the “Herceptin (Trastuzumab) Industry Forecast” looks at past sales and reviews total world Herceptin (Trastuzumab) sales in 2022, providing a comprehensive analysis by region and market sector of projected Herceptin (Trastuzumab) sales for 2023 through 2029. With Herceptin (Trastuzumab) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Herceptin (Trastuzumab) industry.
This Insight Report provides a comprehensive analysis of the global Herceptin (Trastuzumab) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Herceptin (Trastuzumab) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Herceptin (Trastuzumab) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Herceptin (Trastuzumab) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Herceptin (Trastuzumab).
The global Herceptin (Trastuzumab) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Herceptin (Trastuzumab) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Herceptin (Trastuzumab) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Herceptin (Trastuzumab) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Herceptin (Trastuzumab) players cover Roche Diagnostics, Genentech, Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited and Bio-Techne, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Herceptin (Trastuzumab) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Herceptin (Trastuzumab) market?
What factors are driving Herceptin (Trastuzumab) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Herceptin (Trastuzumab) market opportunities vary by end market size?
How does Herceptin (Trastuzumab) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Herceptin (Trastuzumab) is a monoclonal antibody against Her2, blocks the growth of cancer cells by attaching itself to Her2, preventing epidermal growth factor from attaching to Her2. Herceptin also stimulates the body's own immune cells to destroy cancer cells. Clinically, it is mainly used for metastatic breast cancer with excessive expression of her-2. Monotherapy may be used for metastatic breast cancer that has received one or more chemotherapy regimens; It can be combined with paclitaxel to treat metastatic breast cancer without chemotherapy.
LPI (LP Information)' newest research report, the “Herceptin (Trastuzumab) Industry Forecast” looks at past sales and reviews total world Herceptin (Trastuzumab) sales in 2022, providing a comprehensive analysis by region and market sector of projected Herceptin (Trastuzumab) sales for 2023 through 2029. With Herceptin (Trastuzumab) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Herceptin (Trastuzumab) industry.
This Insight Report provides a comprehensive analysis of the global Herceptin (Trastuzumab) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Herceptin (Trastuzumab) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Herceptin (Trastuzumab) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Herceptin (Trastuzumab) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Herceptin (Trastuzumab).
The global Herceptin (Trastuzumab) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Herceptin (Trastuzumab) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Herceptin (Trastuzumab) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Herceptin (Trastuzumab) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Herceptin (Trastuzumab) players cover Roche Diagnostics, Genentech, Novartis AG, Pfizer, Abnova Corporation, InvivoGen, Celltrion, Biocon Limited and Bio-Techne, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Herceptin (Trastuzumab) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Breast Cancer
- Stomach Cancer
- Others
- Hospital
- Medical Center
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche Diagnostics
- Genentech
- Novartis AG
- Pfizer
- Abnova Corporation
- InvivoGen
- Celltrion
- Biocon Limited
- Bio-Techne
- Amgen
- Samsung Bioepis
- Merck
- Mylan
- Teva Pharmaceutical
- Mundipharma
- Mabion
- AryoGen Biopharma
- Genor Biopharma
What is the 10-year outlook for the global Herceptin (Trastuzumab) market?
What factors are driving Herceptin (Trastuzumab) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Herceptin (Trastuzumab) market opportunities vary by end market size?
How does Herceptin (Trastuzumab) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Herceptin (Trastuzumab) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Herceptin (Trastuzumab) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Herceptin (Trastuzumab) by Country/Region, 2018, 2022 & 2029
2.2 Herceptin (Trastuzumab) Segment by Type
2.2.1 Breast Cancer
2.2.2 Stomach Cancer
2.2.3 Others
2.3 Herceptin (Trastuzumab) Sales by Type
2.3.1 Global Herceptin (Trastuzumab) Sales Market Share by Type (2018-2023)
2.3.2 Global Herceptin (Trastuzumab) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Herceptin (Trastuzumab) Sale Price by Type (2018-2023)
2.4 Herceptin (Trastuzumab) Segment by Application
2.4.1 Hospital
2.4.2 Medical Center
2.5 Herceptin (Trastuzumab) Sales by Application
2.5.1 Global Herceptin (Trastuzumab) Sale Market Share by Application (2018-2023)
2.5.2 Global Herceptin (Trastuzumab) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Herceptin (Trastuzumab) Sale Price by Application (2018-2023)
3 GLOBAL HERCEPTIN (TRASTUZUMAB) BY COMPANY
3.1 Global Herceptin (Trastuzumab) Breakdown Data by Company
3.1.1 Global Herceptin (Trastuzumab) Annual Sales by Company (2018-2023)
3.1.2 Global Herceptin (Trastuzumab) Sales Market Share by Company (2018-2023)
3.2 Global Herceptin (Trastuzumab) Annual Revenue by Company (2018-2023)
3.2.1 Global Herceptin (Trastuzumab) Revenue by Company (2018-2023)
3.2.2 Global Herceptin (Trastuzumab) Revenue Market Share by Company (2018-2023)
3.3 Global Herceptin (Trastuzumab) Sale Price by Company
3.4 Key Manufacturers Herceptin (Trastuzumab) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Herceptin (Trastuzumab) Product Location Distribution
3.4.2 Players Herceptin (Trastuzumab) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HERCEPTIN (TRASTUZUMAB) BY GEOGRAPHIC REGION
4.1 World Historic Herceptin (Trastuzumab) Market Size by Geographic Region (2018-2023)
4.1.1 Global Herceptin (Trastuzumab) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Herceptin (Trastuzumab) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Herceptin (Trastuzumab) Market Size by Country/Region (2018-2023)
4.2.1 Global Herceptin (Trastuzumab) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Herceptin (Trastuzumab) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Herceptin (Trastuzumab) Sales Growth
4.4 APAC Herceptin (Trastuzumab) Sales Growth
4.5 Europe Herceptin (Trastuzumab) Sales Growth
4.6 Middle East & Africa Herceptin (Trastuzumab) Sales Growth
5 AMERICAS
5.1 Americas Herceptin (Trastuzumab) Sales by Country
5.1.1 Americas Herceptin (Trastuzumab) Sales by Country (2018-2023)
5.1.2 Americas Herceptin (Trastuzumab) Revenue by Country (2018-2023)
5.2 Americas Herceptin (Trastuzumab) Sales by Type
5.3 Americas Herceptin (Trastuzumab) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Herceptin (Trastuzumab) Sales by Region
6.1.1 APAC Herceptin (Trastuzumab) Sales by Region (2018-2023)
6.1.2 APAC Herceptin (Trastuzumab) Revenue by Region (2018-2023)
6.2 APAC Herceptin (Trastuzumab) Sales by Type
6.3 APAC Herceptin (Trastuzumab) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Herceptin (Trastuzumab) by Country
7.1.1 Europe Herceptin (Trastuzumab) Sales by Country (2018-2023)
7.1.2 Europe Herceptin (Trastuzumab) Revenue by Country (2018-2023)
7.2 Europe Herceptin (Trastuzumab) Sales by Type
7.3 Europe Herceptin (Trastuzumab) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Herceptin (Trastuzumab) by Country
8.1.1 Middle East & Africa Herceptin (Trastuzumab) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Herceptin (Trastuzumab) Revenue by Country (2018-2023)
8.2 Middle East & Africa Herceptin (Trastuzumab) Sales by Type
8.3 Middle East & Africa Herceptin (Trastuzumab) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Herceptin (Trastuzumab)
10.3 Manufacturing Process Analysis of Herceptin (Trastuzumab)
10.4 Industry Chain Structure of Herceptin (Trastuzumab)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Herceptin (Trastuzumab) Distributors
11.3 Herceptin (Trastuzumab) Customer
12 WORLD FORECAST REVIEW FOR HERCEPTIN (TRASTUZUMAB) BY GEOGRAPHIC REGION
12.1 Global Herceptin (Trastuzumab) Market Size Forecast by Region
12.1.1 Global Herceptin (Trastuzumab) Forecast by Region (2024-2029)
12.1.2 Global Herceptin (Trastuzumab) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Herceptin (Trastuzumab) Forecast by Type
12.7 Global Herceptin (Trastuzumab) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Information
13.1.2 Roche Diagnostics Herceptin (Trastuzumab) Product Portfolios and Specifications
13.1.3 Roche Diagnostics Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Diagnostics Main Business Overview
13.1.5 Roche Diagnostics Latest Developments
13.2 Genentech
13.2.1 Genentech Company Information
13.2.2 Genentech Herceptin (Trastuzumab) Product Portfolios and Specifications
13.2.3 Genentech Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Genentech Main Business Overview
13.2.5 Genentech Latest Developments
13.3 Novartis AG
13.3.1 Novartis AG Company Information
13.3.2 Novartis AG Herceptin (Trastuzumab) Product Portfolios and Specifications
13.3.3 Novartis AG Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis AG Main Business Overview
13.3.5 Novartis AG Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Herceptin (Trastuzumab) Product Portfolios and Specifications
13.4.3 Pfizer Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Abnova Corporation
13.5.1 Abnova Corporation Company Information
13.5.2 Abnova Corporation Herceptin (Trastuzumab) Product Portfolios and Specifications
13.5.3 Abnova Corporation Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Abnova Corporation Main Business Overview
13.5.5 Abnova Corporation Latest Developments
13.6 InvivoGen
13.6.1 InvivoGen Company Information
13.6.2 InvivoGen Herceptin (Trastuzumab) Product Portfolios and Specifications
13.6.3 InvivoGen Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 InvivoGen Main Business Overview
13.6.5 InvivoGen Latest Developments
13.7 Celltrion
13.7.1 Celltrion Company Information
13.7.2 Celltrion Herceptin (Trastuzumab) Product Portfolios and Specifications
13.7.3 Celltrion Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Celltrion Main Business Overview
13.7.5 Celltrion Latest Developments
13.8 Biocon Limited
13.8.1 Biocon Limited Company Information
13.8.2 Biocon Limited Herceptin (Trastuzumab) Product Portfolios and Specifications
13.8.3 Biocon Limited Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biocon Limited Main Business Overview
13.8.5 Biocon Limited Latest Developments
13.9 Bio-Techne
13.9.1 Bio-Techne Company Information
13.9.2 Bio-Techne Herceptin (Trastuzumab) Product Portfolios and Specifications
13.9.3 Bio-Techne Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Bio-Techne Main Business Overview
13.9.5 Bio-Techne Latest Developments
13.10 Amgen
13.10.1 Amgen Company Information
13.10.2 Amgen Herceptin (Trastuzumab) Product Portfolios and Specifications
13.10.3 Amgen Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Amgen Main Business Overview
13.10.5 Amgen Latest Developments
13.11 Samsung Bioepis
13.11.1 Samsung Bioepis Company Information
13.11.2 Samsung Bioepis Herceptin (Trastuzumab) Product Portfolios and Specifications
13.11.3 Samsung Bioepis Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Samsung Bioepis Main Business Overview
13.11.5 Samsung Bioepis Latest Developments
13.12 Merck
13.12.1 Merck Company Information
13.12.2 Merck Herceptin (Trastuzumab) Product Portfolios and Specifications
13.12.3 Merck Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Merck Main Business Overview
13.12.5 Merck Latest Developments
13.13 Mylan
13.13.1 Mylan Company Information
13.13.2 Mylan Herceptin (Trastuzumab) Product Portfolios and Specifications
13.13.3 Mylan Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Mylan Main Business Overview
13.13.5 Mylan Latest Developments
13.14 Teva Pharmaceutical
13.14.1 Teva Pharmaceutical Company Information
13.14.2 Teva Pharmaceutical Herceptin (Trastuzumab) Product Portfolios and Specifications
13.14.3 Teva Pharmaceutical Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Teva Pharmaceutical Main Business Overview
13.14.5 Teva Pharmaceutical Latest Developments
13.15 Mundipharma
13.15.1 Mundipharma Company Information
13.15.2 Mundipharma Herceptin (Trastuzumab) Product Portfolios and Specifications
13.15.3 Mundipharma Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Mundipharma Main Business Overview
13.15.5 Mundipharma Latest Developments
13.16 Mabion
13.16.1 Mabion Company Information
13.16.2 Mabion Herceptin (Trastuzumab) Product Portfolios and Specifications
13.16.3 Mabion Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Mabion Main Business Overview
13.16.5 Mabion Latest Developments
13.17 AryoGen Biopharma
13.17.1 AryoGen Biopharma Company Information
13.17.2 AryoGen Biopharma Herceptin (Trastuzumab) Product Portfolios and Specifications
13.17.3 AryoGen Biopharma Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 AryoGen Biopharma Main Business Overview
13.17.5 AryoGen Biopharma Latest Developments
13.18 Genor Biopharma
13.18.1 Genor Biopharma Company Information
13.18.2 Genor Biopharma Herceptin (Trastuzumab) Product Portfolios and Specifications
13.18.3 Genor Biopharma Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Genor Biopharma Main Business Overview
13.18.5 Genor Biopharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Herceptin (Trastuzumab) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Herceptin (Trastuzumab) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Herceptin (Trastuzumab) by Country/Region, 2018, 2022 & 2029
2.2 Herceptin (Trastuzumab) Segment by Type
2.2.1 Breast Cancer
2.2.2 Stomach Cancer
2.2.3 Others
2.3 Herceptin (Trastuzumab) Sales by Type
2.3.1 Global Herceptin (Trastuzumab) Sales Market Share by Type (2018-2023)
2.3.2 Global Herceptin (Trastuzumab) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Herceptin (Trastuzumab) Sale Price by Type (2018-2023)
2.4 Herceptin (Trastuzumab) Segment by Application
2.4.1 Hospital
2.4.2 Medical Center
2.5 Herceptin (Trastuzumab) Sales by Application
2.5.1 Global Herceptin (Trastuzumab) Sale Market Share by Application (2018-2023)
2.5.2 Global Herceptin (Trastuzumab) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Herceptin (Trastuzumab) Sale Price by Application (2018-2023)
3 GLOBAL HERCEPTIN (TRASTUZUMAB) BY COMPANY
3.1 Global Herceptin (Trastuzumab) Breakdown Data by Company
3.1.1 Global Herceptin (Trastuzumab) Annual Sales by Company (2018-2023)
3.1.2 Global Herceptin (Trastuzumab) Sales Market Share by Company (2018-2023)
3.2 Global Herceptin (Trastuzumab) Annual Revenue by Company (2018-2023)
3.2.1 Global Herceptin (Trastuzumab) Revenue by Company (2018-2023)
3.2.2 Global Herceptin (Trastuzumab) Revenue Market Share by Company (2018-2023)
3.3 Global Herceptin (Trastuzumab) Sale Price by Company
3.4 Key Manufacturers Herceptin (Trastuzumab) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Herceptin (Trastuzumab) Product Location Distribution
3.4.2 Players Herceptin (Trastuzumab) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HERCEPTIN (TRASTUZUMAB) BY GEOGRAPHIC REGION
4.1 World Historic Herceptin (Trastuzumab) Market Size by Geographic Region (2018-2023)
4.1.1 Global Herceptin (Trastuzumab) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Herceptin (Trastuzumab) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Herceptin (Trastuzumab) Market Size by Country/Region (2018-2023)
4.2.1 Global Herceptin (Trastuzumab) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Herceptin (Trastuzumab) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Herceptin (Trastuzumab) Sales Growth
4.4 APAC Herceptin (Trastuzumab) Sales Growth
4.5 Europe Herceptin (Trastuzumab) Sales Growth
4.6 Middle East & Africa Herceptin (Trastuzumab) Sales Growth
5 AMERICAS
5.1 Americas Herceptin (Trastuzumab) Sales by Country
5.1.1 Americas Herceptin (Trastuzumab) Sales by Country (2018-2023)
5.1.2 Americas Herceptin (Trastuzumab) Revenue by Country (2018-2023)
5.2 Americas Herceptin (Trastuzumab) Sales by Type
5.3 Americas Herceptin (Trastuzumab) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Herceptin (Trastuzumab) Sales by Region
6.1.1 APAC Herceptin (Trastuzumab) Sales by Region (2018-2023)
6.1.2 APAC Herceptin (Trastuzumab) Revenue by Region (2018-2023)
6.2 APAC Herceptin (Trastuzumab) Sales by Type
6.3 APAC Herceptin (Trastuzumab) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Herceptin (Trastuzumab) by Country
7.1.1 Europe Herceptin (Trastuzumab) Sales by Country (2018-2023)
7.1.2 Europe Herceptin (Trastuzumab) Revenue by Country (2018-2023)
7.2 Europe Herceptin (Trastuzumab) Sales by Type
7.3 Europe Herceptin (Trastuzumab) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Herceptin (Trastuzumab) by Country
8.1.1 Middle East & Africa Herceptin (Trastuzumab) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Herceptin (Trastuzumab) Revenue by Country (2018-2023)
8.2 Middle East & Africa Herceptin (Trastuzumab) Sales by Type
8.3 Middle East & Africa Herceptin (Trastuzumab) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Herceptin (Trastuzumab)
10.3 Manufacturing Process Analysis of Herceptin (Trastuzumab)
10.4 Industry Chain Structure of Herceptin (Trastuzumab)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Herceptin (Trastuzumab) Distributors
11.3 Herceptin (Trastuzumab) Customer
12 WORLD FORECAST REVIEW FOR HERCEPTIN (TRASTUZUMAB) BY GEOGRAPHIC REGION
12.1 Global Herceptin (Trastuzumab) Market Size Forecast by Region
12.1.1 Global Herceptin (Trastuzumab) Forecast by Region (2024-2029)
12.1.2 Global Herceptin (Trastuzumab) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Herceptin (Trastuzumab) Forecast by Type
12.7 Global Herceptin (Trastuzumab) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Information
13.1.2 Roche Diagnostics Herceptin (Trastuzumab) Product Portfolios and Specifications
13.1.3 Roche Diagnostics Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Diagnostics Main Business Overview
13.1.5 Roche Diagnostics Latest Developments
13.2 Genentech
13.2.1 Genentech Company Information
13.2.2 Genentech Herceptin (Trastuzumab) Product Portfolios and Specifications
13.2.3 Genentech Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Genentech Main Business Overview
13.2.5 Genentech Latest Developments
13.3 Novartis AG
13.3.1 Novartis AG Company Information
13.3.2 Novartis AG Herceptin (Trastuzumab) Product Portfolios and Specifications
13.3.3 Novartis AG Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novartis AG Main Business Overview
13.3.5 Novartis AG Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Herceptin (Trastuzumab) Product Portfolios and Specifications
13.4.3 Pfizer Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Abnova Corporation
13.5.1 Abnova Corporation Company Information
13.5.2 Abnova Corporation Herceptin (Trastuzumab) Product Portfolios and Specifications
13.5.3 Abnova Corporation Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Abnova Corporation Main Business Overview
13.5.5 Abnova Corporation Latest Developments
13.6 InvivoGen
13.6.1 InvivoGen Company Information
13.6.2 InvivoGen Herceptin (Trastuzumab) Product Portfolios and Specifications
13.6.3 InvivoGen Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 InvivoGen Main Business Overview
13.6.5 InvivoGen Latest Developments
13.7 Celltrion
13.7.1 Celltrion Company Information
13.7.2 Celltrion Herceptin (Trastuzumab) Product Portfolios and Specifications
13.7.3 Celltrion Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Celltrion Main Business Overview
13.7.5 Celltrion Latest Developments
13.8 Biocon Limited
13.8.1 Biocon Limited Company Information
13.8.2 Biocon Limited Herceptin (Trastuzumab) Product Portfolios and Specifications
13.8.3 Biocon Limited Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Biocon Limited Main Business Overview
13.8.5 Biocon Limited Latest Developments
13.9 Bio-Techne
13.9.1 Bio-Techne Company Information
13.9.2 Bio-Techne Herceptin (Trastuzumab) Product Portfolios and Specifications
13.9.3 Bio-Techne Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Bio-Techne Main Business Overview
13.9.5 Bio-Techne Latest Developments
13.10 Amgen
13.10.1 Amgen Company Information
13.10.2 Amgen Herceptin (Trastuzumab) Product Portfolios and Specifications
13.10.3 Amgen Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Amgen Main Business Overview
13.10.5 Amgen Latest Developments
13.11 Samsung Bioepis
13.11.1 Samsung Bioepis Company Information
13.11.2 Samsung Bioepis Herceptin (Trastuzumab) Product Portfolios and Specifications
13.11.3 Samsung Bioepis Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Samsung Bioepis Main Business Overview
13.11.5 Samsung Bioepis Latest Developments
13.12 Merck
13.12.1 Merck Company Information
13.12.2 Merck Herceptin (Trastuzumab) Product Portfolios and Specifications
13.12.3 Merck Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Merck Main Business Overview
13.12.5 Merck Latest Developments
13.13 Mylan
13.13.1 Mylan Company Information
13.13.2 Mylan Herceptin (Trastuzumab) Product Portfolios and Specifications
13.13.3 Mylan Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Mylan Main Business Overview
13.13.5 Mylan Latest Developments
13.14 Teva Pharmaceutical
13.14.1 Teva Pharmaceutical Company Information
13.14.2 Teva Pharmaceutical Herceptin (Trastuzumab) Product Portfolios and Specifications
13.14.3 Teva Pharmaceutical Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Teva Pharmaceutical Main Business Overview
13.14.5 Teva Pharmaceutical Latest Developments
13.15 Mundipharma
13.15.1 Mundipharma Company Information
13.15.2 Mundipharma Herceptin (Trastuzumab) Product Portfolios and Specifications
13.15.3 Mundipharma Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Mundipharma Main Business Overview
13.15.5 Mundipharma Latest Developments
13.16 Mabion
13.16.1 Mabion Company Information
13.16.2 Mabion Herceptin (Trastuzumab) Product Portfolios and Specifications
13.16.3 Mabion Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Mabion Main Business Overview
13.16.5 Mabion Latest Developments
13.17 AryoGen Biopharma
13.17.1 AryoGen Biopharma Company Information
13.17.2 AryoGen Biopharma Herceptin (Trastuzumab) Product Portfolios and Specifications
13.17.3 AryoGen Biopharma Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 AryoGen Biopharma Main Business Overview
13.17.5 AryoGen Biopharma Latest Developments
13.18 Genor Biopharma
13.18.1 Genor Biopharma Company Information
13.18.2 Genor Biopharma Herceptin (Trastuzumab) Product Portfolios and Specifications
13.18.3 Genor Biopharma Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Genor Biopharma Main Business Overview
13.18.5 Genor Biopharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Herceptin (Trastuzumab) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Herceptin (Trastuzumab) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Breast Cancer
Table 4. Major Players of Stomach Cancer
Table 5. Major Players of Others
Table 6. Global Herceptin (Trastuzumab) Sales by Type (2018-2023) & (K Units)
Table 7. Global Herceptin (Trastuzumab) Sales Market Share by Type (2018-2023)
Table 8. Global Herceptin (Trastuzumab) Revenue by Type (2018-2023) & ($ million)
Table 9. Global Herceptin (Trastuzumab) Revenue Market Share by Type (2018-2023)
Table 10. Global Herceptin (Trastuzumab) Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Herceptin (Trastuzumab) Sales by Application (2018-2023) & (K Units)
Table 12. Global Herceptin (Trastuzumab) Sales Market Share by Application (2018-2023)
Table 13. Global Herceptin (Trastuzumab) Revenue by Application (2018-2023)
Table 14. Global Herceptin (Trastuzumab) Revenue Market Share by Application (2018-2023)
Table 15. Global Herceptin (Trastuzumab) Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Herceptin (Trastuzumab) Sales by Company (2018-2023) & (K Units)
Table 17. Global Herceptin (Trastuzumab) Sales Market Share by Company (2018-2023)
Table 18. Global Herceptin (Trastuzumab) Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Herceptin (Trastuzumab) Revenue Market Share by Company (2018-2023)
Table 20. Global Herceptin (Trastuzumab) Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Herceptin (Trastuzumab) Producing Area Distribution and Sales Area
Table 22. Players Herceptin (Trastuzumab) Products Offered
Table 23. Herceptin (Trastuzumab) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Herceptin (Trastuzumab) Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Herceptin (Trastuzumab) Sales Market Share Geographic Region (2018-2023)
Table 28. Global Herceptin (Trastuzumab) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Herceptin (Trastuzumab) Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Herceptin (Trastuzumab) Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Herceptin (Trastuzumab) Sales Market Share by Country/Region (2018-2023)
Table 32. Global Herceptin (Trastuzumab) Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Herceptin (Trastuzumab) Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Herceptin (Trastuzumab) Sales by Country (2018-2023) & (K Units)
Table 35. Americas Herceptin (Trastuzumab) Sales Market Share by Country (2018-2023)
Table 36. Americas Herceptin (Trastuzumab) Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Herceptin (Trastuzumab) Revenue Market Share by Country (2018-2023)
Table 38. Americas Herceptin (Trastuzumab) Sales by Type (2018-2023) & (K Units)
Table 39. Americas Herceptin (Trastuzumab) Sales by Application (2018-2023) & (K Units)
Table 40. APAC Herceptin (Trastuzumab) Sales by Region (2018-2023) & (K Units)
Table 41. APAC Herceptin (Trastuzumab) Sales Market Share by Region (2018-2023)
Table 42. APAC Herceptin (Trastuzumab) Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Herceptin (Trastuzumab) Revenue Market Share by Region (2018-2023)
Table 44. APAC Herceptin (Trastuzumab) Sales by Type (2018-2023) & (K Units)
Table 45. APAC Herceptin (Trastuzumab) Sales by Application (2018-2023) & (K Units)
Table 46. Europe Herceptin (Trastuzumab) Sales by Country (2018-2023) & (K Units)
Table 47. Europe Herceptin (Trastuzumab) Sales Market Share by Country (2018-2023)
Table 48. Europe Herceptin (Trastuzumab) Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Herceptin (Trastuzumab) Revenue Market Share by Country (2018-2023)
Table 50. Europe Herceptin (Trastuzumab) Sales by Type (2018-2023) & (K Units)
Table 51. Europe Herceptin (Trastuzumab) Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Herceptin (Trastuzumab) Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Herceptin (Trastuzumab) Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Herceptin (Trastuzumab) Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Herceptin (Trastuzumab) Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Herceptin (Trastuzumab) Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Herceptin (Trastuzumab) Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Herceptin (Trastuzumab)
Table 59. Key Market Challenges & Risks of Herceptin (Trastuzumab)
Table 60. Key Industry Trends of Herceptin (Trastuzumab)
Table 61. Herceptin (Trastuzumab) Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Herceptin (Trastuzumab) Distributors List
Table 64. Herceptin (Trastuzumab) Customer List
Table 65. Global Herceptin (Trastuzumab) Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Herceptin (Trastuzumab) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Herceptin (Trastuzumab) Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Herceptin (Trastuzumab) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Herceptin (Trastuzumab) Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Herceptin (Trastuzumab) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Herceptin (Trastuzumab) Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Herceptin (Trastuzumab) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Herceptin (Trastuzumab) Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Herceptin (Trastuzumab) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Herceptin (Trastuzumab) Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Herceptin (Trastuzumab) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Herceptin (Trastuzumab) Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Herceptin (Trastuzumab) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Roche Diagnostics Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 80. Roche Diagnostics Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 81. Roche Diagnostics Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Roche Diagnostics Main Business
Table 83. Roche Diagnostics Latest Developments
Table 84. Genentech Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 85. Genentech Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 86. Genentech Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Genentech Main Business
Table 88. Genentech Latest Developments
Table 89. Novartis AG Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 90. Novartis AG Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 91. Novartis AG Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Novartis AG Main Business
Table 93. Novartis AG Latest Developments
Table 94. Pfizer Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 96. Pfizer Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Abnova Corporation Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 100. Abnova Corporation Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 101. Abnova Corporation Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Abnova Corporation Main Business
Table 103. Abnova Corporation Latest Developments
Table 104. InvivoGen Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 105. InvivoGen Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 106. InvivoGen Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. InvivoGen Main Business
Table 108. InvivoGen Latest Developments
Table 109. Celltrion Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 110. Celltrion Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 111. Celltrion Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Celltrion Main Business
Table 113. Celltrion Latest Developments
Table 114. Biocon Limited Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 115. Biocon Limited Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 116. Biocon Limited Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Biocon Limited Main Business
Table 118. Biocon Limited Latest Developments
Table 119. Bio-Techne Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 120. Bio-Techne Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 121. Bio-Techne Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Bio-Techne Main Business
Table 123. Bio-Techne Latest Developments
Table 124. Amgen Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 125. Amgen Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 126. Amgen Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Amgen Main Business
Table 128. Amgen Latest Developments
Table 129. Samsung Bioepis Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 130. Samsung Bioepis Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 131. Samsung Bioepis Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Samsung Bioepis Main Business
Table 133. Samsung Bioepis Latest Developments
Table 134. Merck Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 135. Merck Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 136. Merck Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 137. Merck Main Business
Table 138. Merck Latest Developments
Table 139. Mylan Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 140. Mylan Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 141. Mylan Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 142. Mylan Main Business
Table 143. Mylan Latest Developments
Table 144. Teva Pharmaceutical Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 145. Teva Pharmaceutical Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 146. Teva Pharmaceutical Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 147. Teva Pharmaceutical Main Business
Table 148. Teva Pharmaceutical Latest Developments
Table 149. Mundipharma Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 150. Mundipharma Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 151. Mundipharma Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 152. Mundipharma Main Business
Table 153. Mundipharma Latest Developments
Table 154. Mabion Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 155. Mabion Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 156. Mabion Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 157. Mabion Main Business
Table 158. Mabion Latest Developments
Table 159. AryoGen Biopharma Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 160. AryoGen Biopharma Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 161. AryoGen Biopharma Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 162. AryoGen Biopharma Main Business
Table 163. AryoGen Biopharma Latest Developments
Table 164. Genor Biopharma Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 165. Genor Biopharma Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 166. Genor Biopharma Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 167. Genor Biopharma Main Business
Table 168. Genor Biopharma Latest Developments
Table 1. Herceptin (Trastuzumab) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Herceptin (Trastuzumab) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Breast Cancer
Table 4. Major Players of Stomach Cancer
Table 5. Major Players of Others
Table 6. Global Herceptin (Trastuzumab) Sales by Type (2018-2023) & (K Units)
Table 7. Global Herceptin (Trastuzumab) Sales Market Share by Type (2018-2023)
Table 8. Global Herceptin (Trastuzumab) Revenue by Type (2018-2023) & ($ million)
Table 9. Global Herceptin (Trastuzumab) Revenue Market Share by Type (2018-2023)
Table 10. Global Herceptin (Trastuzumab) Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Herceptin (Trastuzumab) Sales by Application (2018-2023) & (K Units)
Table 12. Global Herceptin (Trastuzumab) Sales Market Share by Application (2018-2023)
Table 13. Global Herceptin (Trastuzumab) Revenue by Application (2018-2023)
Table 14. Global Herceptin (Trastuzumab) Revenue Market Share by Application (2018-2023)
Table 15. Global Herceptin (Trastuzumab) Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Herceptin (Trastuzumab) Sales by Company (2018-2023) & (K Units)
Table 17. Global Herceptin (Trastuzumab) Sales Market Share by Company (2018-2023)
Table 18. Global Herceptin (Trastuzumab) Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Herceptin (Trastuzumab) Revenue Market Share by Company (2018-2023)
Table 20. Global Herceptin (Trastuzumab) Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Herceptin (Trastuzumab) Producing Area Distribution and Sales Area
Table 22. Players Herceptin (Trastuzumab) Products Offered
Table 23. Herceptin (Trastuzumab) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Herceptin (Trastuzumab) Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Herceptin (Trastuzumab) Sales Market Share Geographic Region (2018-2023)
Table 28. Global Herceptin (Trastuzumab) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Herceptin (Trastuzumab) Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Herceptin (Trastuzumab) Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Herceptin (Trastuzumab) Sales Market Share by Country/Region (2018-2023)
Table 32. Global Herceptin (Trastuzumab) Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Herceptin (Trastuzumab) Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Herceptin (Trastuzumab) Sales by Country (2018-2023) & (K Units)
Table 35. Americas Herceptin (Trastuzumab) Sales Market Share by Country (2018-2023)
Table 36. Americas Herceptin (Trastuzumab) Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Herceptin (Trastuzumab) Revenue Market Share by Country (2018-2023)
Table 38. Americas Herceptin (Trastuzumab) Sales by Type (2018-2023) & (K Units)
Table 39. Americas Herceptin (Trastuzumab) Sales by Application (2018-2023) & (K Units)
Table 40. APAC Herceptin (Trastuzumab) Sales by Region (2018-2023) & (K Units)
Table 41. APAC Herceptin (Trastuzumab) Sales Market Share by Region (2018-2023)
Table 42. APAC Herceptin (Trastuzumab) Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Herceptin (Trastuzumab) Revenue Market Share by Region (2018-2023)
Table 44. APAC Herceptin (Trastuzumab) Sales by Type (2018-2023) & (K Units)
Table 45. APAC Herceptin (Trastuzumab) Sales by Application (2018-2023) & (K Units)
Table 46. Europe Herceptin (Trastuzumab) Sales by Country (2018-2023) & (K Units)
Table 47. Europe Herceptin (Trastuzumab) Sales Market Share by Country (2018-2023)
Table 48. Europe Herceptin (Trastuzumab) Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Herceptin (Trastuzumab) Revenue Market Share by Country (2018-2023)
Table 50. Europe Herceptin (Trastuzumab) Sales by Type (2018-2023) & (K Units)
Table 51. Europe Herceptin (Trastuzumab) Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Herceptin (Trastuzumab) Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Herceptin (Trastuzumab) Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Herceptin (Trastuzumab) Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Herceptin (Trastuzumab) Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Herceptin (Trastuzumab) Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Herceptin (Trastuzumab) Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Herceptin (Trastuzumab)
Table 59. Key Market Challenges & Risks of Herceptin (Trastuzumab)
Table 60. Key Industry Trends of Herceptin (Trastuzumab)
Table 61. Herceptin (Trastuzumab) Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Herceptin (Trastuzumab) Distributors List
Table 64. Herceptin (Trastuzumab) Customer List
Table 65. Global Herceptin (Trastuzumab) Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Herceptin (Trastuzumab) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Herceptin (Trastuzumab) Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Herceptin (Trastuzumab) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Herceptin (Trastuzumab) Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Herceptin (Trastuzumab) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Herceptin (Trastuzumab) Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Herceptin (Trastuzumab) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Herceptin (Trastuzumab) Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Herceptin (Trastuzumab) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Herceptin (Trastuzumab) Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Herceptin (Trastuzumab) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Herceptin (Trastuzumab) Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Herceptin (Trastuzumab) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Roche Diagnostics Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 80. Roche Diagnostics Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 81. Roche Diagnostics Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Roche Diagnostics Main Business
Table 83. Roche Diagnostics Latest Developments
Table 84. Genentech Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 85. Genentech Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 86. Genentech Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Genentech Main Business
Table 88. Genentech Latest Developments
Table 89. Novartis AG Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 90. Novartis AG Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 91. Novartis AG Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Novartis AG Main Business
Table 93. Novartis AG Latest Developments
Table 94. Pfizer Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 95. Pfizer Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 96. Pfizer Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Pfizer Main Business
Table 98. Pfizer Latest Developments
Table 99. Abnova Corporation Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 100. Abnova Corporation Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 101. Abnova Corporation Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Abnova Corporation Main Business
Table 103. Abnova Corporation Latest Developments
Table 104. InvivoGen Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 105. InvivoGen Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 106. InvivoGen Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. InvivoGen Main Business
Table 108. InvivoGen Latest Developments
Table 109. Celltrion Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 110. Celltrion Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 111. Celltrion Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. Celltrion Main Business
Table 113. Celltrion Latest Developments
Table 114. Biocon Limited Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 115. Biocon Limited Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 116. Biocon Limited Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Biocon Limited Main Business
Table 118. Biocon Limited Latest Developments
Table 119. Bio-Techne Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 120. Bio-Techne Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 121. Bio-Techne Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. Bio-Techne Main Business
Table 123. Bio-Techne Latest Developments
Table 124. Amgen Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 125. Amgen Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 126. Amgen Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Amgen Main Business
Table 128. Amgen Latest Developments
Table 129. Samsung Bioepis Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 130. Samsung Bioepis Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 131. Samsung Bioepis Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 132. Samsung Bioepis Main Business
Table 133. Samsung Bioepis Latest Developments
Table 134. Merck Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 135. Merck Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 136. Merck Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 137. Merck Main Business
Table 138. Merck Latest Developments
Table 139. Mylan Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 140. Mylan Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 141. Mylan Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 142. Mylan Main Business
Table 143. Mylan Latest Developments
Table 144. Teva Pharmaceutical Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 145. Teva Pharmaceutical Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 146. Teva Pharmaceutical Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 147. Teva Pharmaceutical Main Business
Table 148. Teva Pharmaceutical Latest Developments
Table 149. Mundipharma Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 150. Mundipharma Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 151. Mundipharma Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 152. Mundipharma Main Business
Table 153. Mundipharma Latest Developments
Table 154. Mabion Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 155. Mabion Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 156. Mabion Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 157. Mabion Main Business
Table 158. Mabion Latest Developments
Table 159. AryoGen Biopharma Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 160. AryoGen Biopharma Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 161. AryoGen Biopharma Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 162. AryoGen Biopharma Main Business
Table 163. AryoGen Biopharma Latest Developments
Table 164. Genor Biopharma Basic Information, Herceptin (Trastuzumab) Manufacturing Base, Sales Area and Its Competitors
Table 165. Genor Biopharma Herceptin (Trastuzumab) Product Portfolios and Specifications
Table 166. Genor Biopharma Herceptin (Trastuzumab) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 167. Genor Biopharma Main Business
Table 168. Genor Biopharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Herceptin (Trastuzumab)
Figure 2. Herceptin (Trastuzumab) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Herceptin (Trastuzumab) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Herceptin (Trastuzumab) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Herceptin (Trastuzumab) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Breast Cancer
Figure 10. Product Picture of Stomach Cancer
Figure 11. Product Picture of Others
Figure 12. Global Herceptin (Trastuzumab) Sales Market Share by Type in 2022
Figure 13. Global Herceptin (Trastuzumab) Revenue Market Share by Type (2018-2023)
Figure 14. Herceptin (Trastuzumab) Consumed in Hospital
Figure 15. Global Herceptin (Trastuzumab) Market: Hospital (2018-2023) & (K Units)
Figure 16. Herceptin (Trastuzumab) Consumed in Medical Center
Figure 17. Global Herceptin (Trastuzumab) Market: Medical Center (2018-2023) & (K Units)
Figure 18. Global Herceptin (Trastuzumab) Sales Market Share by Application (2022)
Figure 19. Global Herceptin (Trastuzumab) Revenue Market Share by Application in 2022
Figure 20. Herceptin (Trastuzumab) Sales Market by Company in 2022 (K Units)
Figure 21. Global Herceptin (Trastuzumab) Sales Market Share by Company in 2022
Figure 22. Herceptin (Trastuzumab) Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Herceptin (Trastuzumab) Revenue Market Share by Company in 2022
Figure 24. Global Herceptin (Trastuzumab) Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Herceptin (Trastuzumab) Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Herceptin (Trastuzumab) Sales 2018-2023 (K Units)
Figure 27. Americas Herceptin (Trastuzumab) Revenue 2018-2023 ($ Millions)
Figure 28. APAC Herceptin (Trastuzumab) Sales 2018-2023 (K Units)
Figure 29. APAC Herceptin (Trastuzumab) Revenue 2018-2023 ($ Millions)
Figure 30. Europe Herceptin (Trastuzumab) Sales 2018-2023 (K Units)
Figure 31. Europe Herceptin (Trastuzumab) Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Herceptin (Trastuzumab) Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Herceptin (Trastuzumab) Revenue 2018-2023 ($ Millions)
Figure 34. Americas Herceptin (Trastuzumab) Sales Market Share by Country in 2022
Figure 35. Americas Herceptin (Trastuzumab) Revenue Market Share by Country in 2022
Figure 36. Americas Herceptin (Trastuzumab) Sales Market Share by Type (2018-2023)
Figure 37. Americas Herceptin (Trastuzumab) Sales Market Share by Application (2018-2023)
Figure 38. United States Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Herceptin (Trastuzumab) Sales Market Share by Region in 2022
Figure 43. APAC Herceptin (Trastuzumab) Revenue Market Share by Regions in 2022
Figure 44. APAC Herceptin (Trastuzumab) Sales Market Share by Type (2018-2023)
Figure 45. APAC Herceptin (Trastuzumab) Sales Market Share by Application (2018-2023)
Figure 46. China Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Herceptin (Trastuzumab) Sales Market Share by Country in 2022
Figure 54. Europe Herceptin (Trastuzumab) Revenue Market Share by Country in 2022
Figure 55. Europe Herceptin (Trastuzumab) Sales Market Share by Type (2018-2023)
Figure 56. Europe Herceptin (Trastuzumab) Sales Market Share by Application (2018-2023)
Figure 57. Germany Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Herceptin (Trastuzumab) Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Herceptin (Trastuzumab) Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Herceptin (Trastuzumab) Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Herceptin (Trastuzumab) Sales Market Share by Application (2018-2023)
Figure 66. Egypt Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Herceptin (Trastuzumab) in 2022
Figure 72. Manufacturing Process Analysis of Herceptin (Trastuzumab)
Figure 73. Industry Chain Structure of Herceptin (Trastuzumab)
Figure 74. Channels of Distribution
Figure 75. Global Herceptin (Trastuzumab) Sales Market Forecast by Region (2024-2029)
Figure 76. Global Herceptin (Trastuzumab) Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Herceptin (Trastuzumab) Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Herceptin (Trastuzumab) Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Herceptin (Trastuzumab) Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Herceptin (Trastuzumab) Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Herceptin (Trastuzumab)
Figure 2. Herceptin (Trastuzumab) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Herceptin (Trastuzumab) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Herceptin (Trastuzumab) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Herceptin (Trastuzumab) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Breast Cancer
Figure 10. Product Picture of Stomach Cancer
Figure 11. Product Picture of Others
Figure 12. Global Herceptin (Trastuzumab) Sales Market Share by Type in 2022
Figure 13. Global Herceptin (Trastuzumab) Revenue Market Share by Type (2018-2023)
Figure 14. Herceptin (Trastuzumab) Consumed in Hospital
Figure 15. Global Herceptin (Trastuzumab) Market: Hospital (2018-2023) & (K Units)
Figure 16. Herceptin (Trastuzumab) Consumed in Medical Center
Figure 17. Global Herceptin (Trastuzumab) Market: Medical Center (2018-2023) & (K Units)
Figure 18. Global Herceptin (Trastuzumab) Sales Market Share by Application (2022)
Figure 19. Global Herceptin (Trastuzumab) Revenue Market Share by Application in 2022
Figure 20. Herceptin (Trastuzumab) Sales Market by Company in 2022 (K Units)
Figure 21. Global Herceptin (Trastuzumab) Sales Market Share by Company in 2022
Figure 22. Herceptin (Trastuzumab) Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Herceptin (Trastuzumab) Revenue Market Share by Company in 2022
Figure 24. Global Herceptin (Trastuzumab) Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Herceptin (Trastuzumab) Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Herceptin (Trastuzumab) Sales 2018-2023 (K Units)
Figure 27. Americas Herceptin (Trastuzumab) Revenue 2018-2023 ($ Millions)
Figure 28. APAC Herceptin (Trastuzumab) Sales 2018-2023 (K Units)
Figure 29. APAC Herceptin (Trastuzumab) Revenue 2018-2023 ($ Millions)
Figure 30. Europe Herceptin (Trastuzumab) Sales 2018-2023 (K Units)
Figure 31. Europe Herceptin (Trastuzumab) Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Herceptin (Trastuzumab) Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa Herceptin (Trastuzumab) Revenue 2018-2023 ($ Millions)
Figure 34. Americas Herceptin (Trastuzumab) Sales Market Share by Country in 2022
Figure 35. Americas Herceptin (Trastuzumab) Revenue Market Share by Country in 2022
Figure 36. Americas Herceptin (Trastuzumab) Sales Market Share by Type (2018-2023)
Figure 37. Americas Herceptin (Trastuzumab) Sales Market Share by Application (2018-2023)
Figure 38. United States Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Herceptin (Trastuzumab) Sales Market Share by Region in 2022
Figure 43. APAC Herceptin (Trastuzumab) Revenue Market Share by Regions in 2022
Figure 44. APAC Herceptin (Trastuzumab) Sales Market Share by Type (2018-2023)
Figure 45. APAC Herceptin (Trastuzumab) Sales Market Share by Application (2018-2023)
Figure 46. China Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Herceptin (Trastuzumab) Sales Market Share by Country in 2022
Figure 54. Europe Herceptin (Trastuzumab) Revenue Market Share by Country in 2022
Figure 55. Europe Herceptin (Trastuzumab) Sales Market Share by Type (2018-2023)
Figure 56. Europe Herceptin (Trastuzumab) Sales Market Share by Application (2018-2023)
Figure 57. Germany Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Herceptin (Trastuzumab) Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Herceptin (Trastuzumab) Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Herceptin (Trastuzumab) Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Herceptin (Trastuzumab) Sales Market Share by Application (2018-2023)
Figure 66. Egypt Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Herceptin (Trastuzumab) Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Herceptin (Trastuzumab) in 2022
Figure 72. Manufacturing Process Analysis of Herceptin (Trastuzumab)
Figure 73. Industry Chain Structure of Herceptin (Trastuzumab)
Figure 74. Channels of Distribution
Figure 75. Global Herceptin (Trastuzumab) Sales Market Forecast by Region (2024-2029)
Figure 76. Global Herceptin (Trastuzumab) Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Herceptin (Trastuzumab) Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Herceptin (Trastuzumab) Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Herceptin (Trastuzumab) Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Herceptin (Trastuzumab) Revenue Market Share Forecast by Application (2024-2029)
